[1]
Garvey, W.T. et al. 2022. EFFICACY AND SAFETY OF LIRAGLUTIDE 3.0 mg IN INDIVIDUALS WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES (T2D) TREATED WITH BASAL INSULIN: THE SCALE INSULIN TRIAL. Journal of the ASEAN Federation of Endocrine Societies. 34, 2 (May 2022), 12.